Handelsbanken Fonder Ab Deciphera Pharmaceuticals, Inc. Transaction History

Handelsbanken Fonder Ab

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$7.7 - $37.13 $65,480 - $315,753	-8,504 Closed	0 $0
Q2 2021 Aug 03, 2021	SELL	$32.73 - $47.95 $36,003 - $52,745	-1,100 Reduced 11.45%	8,504 $311,000
Q2 2020 Aug 13, 2020	BUY	$37.05 - $65.03 $355,828 - $624,548	9,604 New	9,604 $574,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

Stay updated on Handelsbanken Fonder Ab with notifications on news.